Website results

These results do not include items from TGA's databases, such as the Database of Adverse Event Notifications, the System for Australian Recall Actions and Medicines Shortages Information.

Did you mean p031 ?

1. Fully-matching results

2. Consultation submission: Medicine labelling

   https://www.tga.gov.au/sites/default/files/consult-labelling-medicines-140822-submission-sgp.pdf
   • Cached
   • Explore

   15 Jan 2015: Dr Steven J Hambleton MBBS FAMA FRACGP(hon) MAICD c/o Kedron Park 7 Day Medical Centre Cnr Gympie and Brookfield Rds Kedron 4031 Phone 3857 6288 Fax 3357 5963 Email;

3. Australian public assessment for Ivabradine

   https://www.tga.gov.au/sites/default/files/auspar-ivabradine-121031.docx
   • Cached
   • Explore

   18 Dec 2012: Therapeutic Goods Administration. October 2012. Australian Public Assessment Report for Ivabradine. Proprietary Product Name: Coralan. Sponsor: Servier Laboratories (Australia). About the Therapeutic Goods Administration (TGA). The Therapeutic Goods

4. Australian public assessment for Ivabradine

   https://www.tga.gov.au/sites/default/files/auspar-ivabradine-121031.pdf
   • Cached
   • Explore

   18 Dec 2012: prescription medicine regulation

5. Australian public assessment for Vernakalant

   https://www.tga.gov.au/sites/default/files/auspar-vernakalant-121112.pdf
   • Cached
   • Explore

   17 Dec 2012: different classes in the Vaughan Williams classification of antiarrhythmic drugs, including flecainide, quinidine, propafenone and lignocaine (all class I sodium channel blockers), dofetilide, E-4031 and tedisamil (all class III potassium

6. Australian public assessment for Vernakalant

   https://www.tga.gov.au/sites/default/files/auspar-vernakalant-121112.docx
   • Cached
   • Explore

   17 Dec 2012: Several studies included comparators from different classes in the Vaughan Williams classification of antiarrhythmic drugs, including flecainide, quinidine, propafenone and lignocaine (all class I sodium channel blockers), dofetilide, E-4031 and